期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝癌组织中HMGA2蛋白、mRNA表达变化及意义 被引量：1

Expression changes and significance of HMGA2 protein and mRNA in hepatocellular carcinoma
下载PDF
导出
摘要 目的观察肝癌组织中高迁移率族蛋白A2(HMGA2)蛋白、mRNA的表达变化,并探讨其临床意义。方法用免疫组织化学SP法检测30例肝癌及其癌旁组织中的HMGA2蛋白,用RT-PCR法检测HMGA2 mRNA。结果 30例肝癌组织中平均HMGA2阳性率35.1%,而癌旁肝组织HMGA2阳性率<1%,两者HMGA2阳性率相比P<0.01。肝癌组织中HMGA2蛋白表达与肝癌Edmondson分级、肝内转移灶和肝门淋巴结转移有关(P均<0.05),与肿瘤直径无关(P>0.05)。癌旁组织和Ⅰ、Ⅱ、Ⅲ、Ⅳ级肝癌组织中HMGA2 mRNA相对表达量分别为0.03±0.02、0.04±0.06、0.10±0.16、0.52±0.87、0.68±0.95。肝癌组织中HMGA2 mRNA相对表达量明显高于癌旁组织(P均<0.05),肝癌组织中HMGA2 mRNA相对表达量与肝癌Edmondson分级有关(P均<0.05)。结论肝癌组织中HMGA2蛋白、mRNA表达升高,其可能参与肝癌的发生发展过程。 Objective To investigate the significance and their expression of HMGA2 protein and mRNA in hepatocel- lular carcinoma （HCC） and their pericarcinomous tissues （PT）. Methods Paraffin embedded tissues from 30 HCC cases and their PT were respectively analysed for HMGA2 protein and mRNA expression by immunohistochemical and RT-PCR method. Results The positive signals were seen in the nucleus. PT of 30 cases were all negative for HMGA2 protein, the positive rate was 0.56%. However, in the HCC 30 cases, 35.1% were positive for HMGA2 protein. The HMGA2 positive rate of HCCs was very significantly higher than that of PT（P 〈 0. 01 ）. The relationship between the HMGA2 protein ex- pression in HCC tissues and clinicopathological parameters see tablel. It can be seen from tablel that the HMGA2 protein expression in HCC tissues was related with the Edmondson grade of hepatocellular carcinoma, liver metastases, and liver portal lymph node metastasis （ P 〈 0.05 ） , and was independent of tumor size. The HMGA2 mRNA relative expression in the pericarcinomous tissues and grade I - 1V HCC was respectively O. 03 ±0.02,0.04 ± 0.06,0.10 ± 0.16,0.52 ± 0.87, 0.68 ± 0.95. The HMGA2 mRNA relative expression in HCC was higher than that of the pericarcinomous tissues （ P 〈 0.05 ）. The HMGA2 mRNA relative expression in HCC was related with the Edmondson grade（P 〈 0.05 ）. Conclusion The HMGA2 protein and mRNA were highly expressed in HCC, which indicated that HMGA2 may be involved in the devel- opment and progression of HCC.
作者 谭丽 谭获 魏小平 杨通
机构地区 广州医学院第一附属医院
出处 《山东医药》 CAS 2012年第22期18-21,共4页 Shandong Medical Journal
基金 国家自然科学基金资助项目(81100379)
关键词 肝肿瘤 肝细胞癌 高迁移率族蛋白 liver neoplasms hepatocellular carcinoma high mobility group protein
分类号 R735.7 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1Grigioni WF, DErrico A, Bacci F, et al. Primary liver neoplasms: evaluation of proliferative index using MoAb Ki67 [ J ]. J Pathol, 1989,158( 1 ) :23-29.
  • 2Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function [ J ]. Gene, 2001,277 ( 1-2 ) : 63-81.
  • 3Fusco A, Fedele M. Roles of HMGA proteins in cancer[ J]. Nat Rev Cancer, 2007,7(12) :899-910.
  • 4Hock R, Furusawa T, Ueda T, et al. HMG chromosomal proteins in development and disease[ J ]. Trends Cell Biol, 2007,17 (2) : 72-79.
  • 5Godley LA. HMGA2 levels in CML: reflective of miRNA gene reg- ulation in a hematopoietic tumor [ J ]. Leuk Lymphoma, 2007,48 (10) :1898-1899.
  • 6Nyquist KB, Panagopoulos I, Thorsen J, et al. ( 12 ; 13 ) ( q14; q31 ) leading to HMGA2 upregulation in acute myeloid leukaemia [J]. Br J Haematol, 2012,157(6) :769-771.
  • 7Motoyama K, Inoue H, Nakamura Y, et al. Clinical significance of high mobility group A2 in human gastric cancer and ils relationship to let-7 microRNA family [ J ]. Clin Cancer Res, 2008,14 ( 8 ) :2334-2340.
  • 8Huang ML, Chen CC, Chang LC. Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorec- tal cancer J. Int J Colorectal Dis, 2009,24( 11 ) :1281-1286.
  • 9Belge G, Meyer A, Klemke M, et al. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish be- tween benign and malignant follicular neoplasias[ J]. Genes Chrom Can, 2008,47( 1 ) :56-63.
  • 10Meyer B, Loeschke S, Schultze A, et al. I-IMGA2 overexpression in non-small cell lung cancer [ J ]. Mol Carcinog, 2007,46 (7) : 503-511.

同被引文献14

  • 1Lee Kraus W, Hottiger MO. PARP-1 and gene regulation: Progress and puzzles[J]. Molecular Aspects of Medicine , 2013, 34(6).,1109-1123.
  • 2Hu Z, Fan C, Oh DS, et al. The Molecular Portraits Of Breast Tumors Are Conserved Across Microarray Platforms[J]. BMC Genomics, 2006, 7:96(6) :96.
  • 3LA C. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study[J]. JAMA, 2006, 295 (21) .. 2492-2502.
  • 4Johnson N,Shapiro GI. Chemotherapy-induced p53-depend- ent and-independent DNA damage responses are enhanced by poly (ADP-ribose) polymerase (PARP) inhibition in BRCA- proficient cancer eells[J]. Cell Cycle, 2012,11 (3) : 432-433.
  • 5Tan [J, Thusult S, Caja L, et al . Regulation of Transcription Factor Twist Expression by the DNA Architectural Protein High Mohility Group A2 during Epithelial-to-Mesenchymal Transition [J]. J Biol Chem, 2012,287(10) :7134-7145.
  • 6PD, TH, JL, et al . PARP-1 expression in breast cancer in- cluding BRCAl-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy. [J]. Breast Cancer Res Treat, 2011, 127(3) :861-869.
  • 7Bianehini L, Sa da E, Gjernes E, et al . Let-7 mieroRNA and HMGA2 levels of expression are not inversely linked in adi- poeytie tumors: analysis of 56 lipomas and liposarcomas with molecular eytogenetie data[J]. Genes Chromosomes Cancer, 2011, 50(6) :442-455.
  • 8Winter N. Chromatin immunopreeipitation to analyze DNA binding sites of HMGA2[J]. PLoS ONE, 2011, 6 (4) : 365- 368.
  • 9TE H, A H, J K, et al . HMGA2 protein expression in o- varian serous carcinoma effusions, primary tumors, and solid metastases[J]. Virchows Archiv, 2012, 460(5):505-513.
  • 10Georgeseu R,Coros MF,Stolnicu S, et al . Prognostic factors in breast cancer[J]. Rev Med Chit Soc Med Nat lasi, 2012, 116(1) :262-267.

引证文献1

山东医药
2012年 第22期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部